(24/7 MARKET NEWS) – INVO Bioscience, Inc. (NASDAQ: INVO) stated, this morning, that it is acquiring Wisconsin Fertility Institute, a fertility center that primarily offers conventional IVF procedures and generated approximately $5.5 million in revenue and net income of approximately $1.9 million for the trailing 12-month period ended September 30, 2022.
INVO Bioscience is trading at $0.6513, up $0.1110 (+20.54%), on 500 thousand premarket shares.
Its 52-week trading range is $0.329 to $2.8368. It’s trading just above a key inflection point and the next key resistance is at $0.79. If it can break through the 79-cent resistance, it may try to challenge to $1 level.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.
Please go to www.247marketnews.com or https://www.247marketnews.com/terms-disclaimer/ for further information.
